Skip to content

Telerehabilitation Education on Anxiety in People with Multiple Sclerosis

The Evaluation of Effect of Telerehabilitation Education on Anxiety in People with Multiple Sclerosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230907059371N1
Enrollment
70
Registered
2023-09-18
Start date
2023-09-21
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis. Multiple sclerosis

Interventions

Intervention 1: Intervention group: Education will be provided by the researcher in 4 sessions, one session per week for 30 to 45 minutes in groups of 4 to 6 people through Skype software.The first s

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age between 18-65 Have recently been diagnosed with MS (maximum one year) and have been confirmed by a specialist. Expanded Disability Status Scale (EDSS) should be 4.0 or less and be approved by a specialist. Should be able to read and write. In case of not being able to read and write, the companion or caregivers of the person with MS should be able to read and write. Having sufficient knowledge In association with electronic devices and computers, or having a skilled person (caregiver of the patient or her/him first-degree relatives) to provide electronic devices Having a personal computer, laptop or smart phone Have active internet access Not participating in other MS education programs at the same time Not suffering from other acute or chronic physical disorders (debilitating heart, respiratory, liver, skeletal-muscular, renal, metabolic or other neurodegenerative diseases) recorded in the file. Not having severe hearing and cognitive disorders recorded in the file

Exclusion criteria

Exclusion criteria: Attending other education sessions. Severe auditory and cognitive disorders recorded in the file Suffering from other acute or chronic physical disorders (debilitating heart, respiratory, liver, skeletal-muscular, renal, metabolic or other neurodegenerative diseases) recorded in the file.

Design outcomes

Primary

MeasureTime frame
Anxiety. Timepoint: Measuring the level of anxiety at the beginning of the study (before the intervention) and 4 weeks after the end of the intervention. Method of measurement: Beck Anxiety questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtieh Sadat Mariani

Iran University of Medical Sciences

Atieh.mariani@gmail.com+98 51 3768 2740

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026